Skip to main content
. 2021 Sep 9;54:101339. doi: 10.1016/j.molmet.2021.101339

Figure 2.

Figure 2

The TAS1R2-(Val) variant is associated with reduced glucose excursions in humans. Plasma excursions of (A) glucose, (B) insulin, (C) C-peptide, (D) glucagon, and (E) active GLP-1 in response to an oral glucose challenge in healthy lean Ile/Ile (black) and Val carriers (red) with normal glucose control (n = 20–26/group). Two-way ANOVA repeated measures, p-value of time x genotype effect.